PeptideDB

β-Sitosterol-d7 (Mixture of Diastereomers) 2260669-28-9

β-Sitosterol-d7 (Mixture of Diastereomers) 2260669-28-9

CAS No.: 2260669-28-9

β-Sitosterol-d7 (Mixture of Diastereomers) is the deuterium labelled form of β-Sitosterol (Mixture of Diastereomers).
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

β-Sitosterol-d7 (Mixture of Diastereomers) is the deuterium labelled form of β-Sitosterol (Mixture of Diastereomers).

Physicochemical Properties


Molecular Formula C29H50O
Molecular Weight 421.75
Exact Mass 421.43
CAS # 2260669-28-9
PubChem CID 57347730
Appearance White to off-white solid powder
LogP 9.3
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 1
Rotatable Bond Count 6
Heavy Atom Count 30
Complexity 634
Defined Atom Stereocenter Count 8
SMILES

[C@H]1(CC2=CC[C@]3([H])[C@@]([H])([C@]2(CC1)C)CC[C@]1([C@@]3([H])CC[C@]1([H])[C@@H](CCC(C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])CC)C)C)O

InChi Key KZJWDPNRJALLNS-GNYYFJBRSA-N
InChi Code

InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21?,23+,24+,25-,26+,27+,28+,29-/m1/s1/i2D3,3D3,19D
Chemical Name

(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-ethyl-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
References

[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.


Solubility Data


Solubility (In Vitro) THF: 50 mg/mL (118.55 mM)
Ethanol: 16.67 mg/mL (39.53 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1 mg/mL (2.37 mM) (saturation unknown) in 10% EtOH + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear EtOH + stock solution to 900 μL of corn oil and mix well.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3711 mL 11.8554 mL 23.7107 mL
5 mM 0.4742 mL 2.3711 mL 4.7421 mL
10 mM 0.2371 mL 1.1855 mL 2.3711 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.